Is a complete PMN research report available?

No complete published report is available for ProMIS Neurosciences, Inc. (PMN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ProMIS Neurosciences, Inc. (PMN)

NASDAQ: PMN · USD

$13.3

-0.15 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-07 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PMN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	119.5M
Net income (ttm)	-40.6M
EPS (ttm)	-$13.4
Shares out	9M
Volume	14,685.127
Beta	-0.22
Price target	$39.4	+195.2%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -40.6M
EPS (ttm): -$13.4
Market cap: 119.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	29.6B	39.4x	6.2x	96.6%	+47.5%	-49.6%	Strong Buy
ARGX	argenx SE	54.1B	31.5x	10.2x	50.6%	+58.8%	+30.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PMN indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001374339
Company name	ProMIS Neurosciences, Inc.
Country	Canada
Country code	US
Cusip	74346M505
Employees	11
Employees Change	3%
Employees Change Percent	37.5
Enterprise value	$55.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	CA74346M5054
Last refreshed	2026-08-07
Market cap	$119.5M
Market cap category	Micro-Cap
Price	$13.33
Price currency	USD
Sector	Healthcare
Sector PE	49.12
Sector PE Fwd	22.46
Sic	2834
Symbol	PMN
Website	https://www.promisneurosciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-33.98%
FCF yield	-29.76%
P/B ratio	1.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-33.4M
Net Income	$-40.6M
Net Income Growth Years	0%
Profit Per Employee	$-3.7M
ROA	-63
Roa5y	-97.99
ROCE	-68.02
ROE	-115.7
Roe5y	-566.7
ROIC	-72.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-22.33%
Cagr1y	-20.43%
Cagr3y	-42.32%
Cagr5y	-45.26%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$67.4M
Cash	$63.8M
Current Assets	$65.6M
Current Liabilities	$6.6M
Debt	$0
Equity	$60.7M
Liabilities	$6.7M
Long Term Assets	$1.8M
Long Term Liabilities	$79,380
Net Cash	$63.8M
Net Cash By Market Cap	$53.41
Net Cash Growth	660.34%
Net Debt Equity	$-1.05
Tangible Book Value	$60.7M
Tangible Book Value Per Share	$6.77
WACC	3.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.92
Net Working Capital	$-4.9M
Quick ratio	9.69
Working Capital	$59M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-155.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-92.01%
1Y total return	-20.42%
200-day SMA	12.02
3Y total return	-80.82%
50-day SMA	12.13
50-day SMA vs 200-day SMA	50over200
5Y total return	-95.08%
All Time High	1,050
All Time High Change	-98.73%
All Time High Date	2017-12-28
All Time Low	6.27
All Time Low Change	112.6%
All Time Low Date	2025-11-28
ATR	1.41
Beta	-0.22
Beta1y	-0.96
Beta2y	0.09
Ch YTD	95.31
High	13.79
High52	27.4
High52 Date	2026-03-05
High52ch	-51.35%
Low	13.27
Low52	6.27
Low52 Date	2025-11-28
Low52ch	112.6%
Ma50ch	9.89%
Price vs 200-day SMA	10.93%
RSI	50.32
RSI Monthly	39.72
RSI Weekly	51.86
Sharpe ratio	0.21x
Sortino ratio	0.38
Total Return	-155.49%
Tr YTD	95.31
Tr1m	-0.15%
Tr1w	-10.66%
Tr3m	20.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	3
Analyst Price Target Top	$42.25
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.84
Operating Income	$-40.9M
Price target	$39.35
Price Target Change	$195
Price Target Change Top	$217

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,597,464%
Float Percent	51.27%
Shares Insiders	11.51%
Shares Institutions	44.78%
Shares Out	8,967,693
Shares Qo Q	153.22%
Shares Yo Y	155.49%
Short Float	5.13%
Short Ratio	4.13
Short Shares	2.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-36.4M
Adjusted OCF	-36,376,991
Average Volume	187,984.1x
Bv Per Share	6.77
Ch10y	-92.01
Ch1m	-0.15
Ch1w	-10.66
Ch1y	-20.42
Ch3m	20.58
Ch3y	-80.82
Ch5y	-95.08
Ch6m	1.76
Change	-1.11%
Change From Open	-0.07
Close	13.48
Days Gap	-1.04
Dollar Volume	195,752.7
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-41.4M
EBITDA	$-41.4M
EPS	$-13.36
F Score	2
FCF	$-35.6M
FCF EV Yield	-63.88x
FCF Per Share	$-3.97
Financing CF	91,025,979
Fiscal Year End	December
Founded	2,004
Investing CF	-702
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2025-11-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-25
Ma150	12.98
Ma150ch	2.72%
Ma20	13.75
Ma20ch	-3.06%
Net CF	55,450,044
Next Earnings Date	2026-08-13
Open	13.34
Optionable	No
Position In Range	11.54
Post Close	13.33
Postmarket Change Percent	3.15
Postmarket Price	$13.75
Price Date	2026-08-06
Ptbv Ratio	1.97
Relative Volume	0.08x
Share Based Comp	801,758
Tr6m	1.76%
Volume	14,685.1

ProMIS Neurosciences, Inc. (PMN)

Coverage state: Market snapshot only — no published research

Generate the first PMN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PMN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PMN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PMN

Frequently asked questions